XML 47 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK PLANS (Details) (USD $)
9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2012
Jan. 26, 2012
Sep. 30, 2012
Employee Stock Purchase Plan [Member]
Sep. 30, 2012
Stock options [Member]
Sep. 30, 2012
Stock options [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2012
Employee Stock Purchase Plan [Member]
Sep. 30, 2012
Employee Stock Purchase Plan [Member]
STOCK PLANS [Abstract]                  
Dividend declared as percentage of stock (in hundredths)   1.00%              
Activity related to stock options [Roll Forward]                  
Options outstanding at Beginning of Period (in shares)       375,563 421,697        
Options Granted (in shares)       0 14,975        
Options Expired (in shares)       0 (61,109)        
Options Cancelled / Forfeited (in shares)       0 0        
Options Exercised (in shares)       0 0        
Options outstanding at End of Period (in shares)       375,563 375,563        
Options Exercisable (vested) at End of Period (in shares)       339,313 339,313        
Options Outstanding, Aggregate Intrinsic Value at End of Period       $ 44,338 $ 44,338        
Options Exercisable, Aggregate Intrinsic Value at End of Period       18,640 18,640        
Stock options weighted average exercise price additional disclosures [Abstract]                  
Weighted average exercise price, options outstanding at beginning of period (in dollars per share)       $ 11.94 $ 11.65        
Weighted average exercise price, Granted (in dollars per share)       $ 0 $ 5.00        
Weighted average exercise price, Expired (in dollars per share)       $ 0 $ 8.24        
Weighted average exercise price, Cancelled / Forfeited (in dollars per share)       $ 0 $ 0        
Weighted average exercise price, Exercised (in dollars per share)       $ 0 $ 0        
Weighted average exercise price, options outstanding at end of period (in dollars per share)       $ 11.94 $ 11.94        
Weighted average exercise price, options exercisable (vested) at end of period (in dollars per share)       $ 12.71 $ 12.71        
Options outstanding, weighted average remaining contractual term       3 years 1 month 13 days 3 years 1 month 13 days        
Options exercisable, weighted average remaining contractual term       2 years 6 months 18 days 2 years 6 months 18 days        
Weighted average fair value of options granted (in dollars per share)         $ 2.4        
Compensation cost not yet recognized, nonvested awards       62,000 62,000 116,000 116,000    
Compensation cost not yet recognized, period for recognition (in years)         2 years 7 months 28 days   2 years 8 months 1 day    
Allocated share-based compensation expense         21,000   44,000   21,000
Weighted average assumptions used in valuation [Abstract]                  
Risk Free Interest Rate (in hundredths)       0.00% [1] 2.37%     0.10% 0.10%
Expected Dividend Yield (in hundredths)       0.00% [1] 0.00%     0.00% 0.00%
Expected Life in Years       0 years 5 years     1 year 1 year
Expected Price Volatility (in hundredths)       0.00% [1] 53.06%     20.00% 20.00%
Activity related to restricted stock [Roll Forward]                  
Restricted stock outstanding at Beginning of Period (in shares)           46,781 46,013    
Restricted stock, Granted (in shares)           0 13,193    
Restricted stock, Cancelled/Forfeited (in shares)           0 (529)    
Restricted stock, Exercised/Released/Vested (in shares)           0 (11,896)    
Restricted stock outstanding at End of Period (in shares)           46,781 46,781    
Restricted stock weighted average grant-date fair value, additional disclosures [Abstract]                  
Restricted stock, weighted average grant-date fair value, beginning of period (in dollars per share)           $ 4.62 $ 7.16    
Restricted stock, weighted average grant-date fair value, granted (in dollars per share)           $ 0 $ 5.00    
Restricted stock, weighted average grant-date fair value, cancelled/forfeited (in dollars per share)           $ 0 $ 9.79    
Restricted stock, weighted average grant-date fair value, exercised/released/vested (in dollars per share)           $ 0 $ 14.64    
Restricted stock, weighted average grant-date fair value, end of period           $ 4.62 $ 4.62    
Restricted stock outstanding, aggregate intrinsic value, end of period           252,617 252,617    
Restricted stock outstanding, weighted average remaining contractual term             8 years 1 month 6 days    
Weighted average fair value of restricted stock granted (in dollars per share)             $ 5    
Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]                  
Shares authorized under plan (in shares)     295,057            
Participation periods for ESPP implementation, maximum 27 months                
Employee Stock Purchase Plan Description The Board of Directors determines the commencement date and duration of each participation period. The Board of Directors approved the current participation period of November 24, 2011 to November 23, 2012.                
Continuous employment period for commencement of a participation period, minimum 90 days                
Maximum compensation percentage withheld for stock purchase plan (in hundredths) 10.00%                
Purchase price of stock in percentage for participation (in hundredths) 85.00%                
Unrecognized compensation cost $ 7,000                
Weighted average fair value at issuance date (in dollars per share) $ 0.99                
Weighted average period to recognize the unrecognized compensation 3 months                
[1] There were no stock options or restricted stock granted during the three-month period ended September 30, 2012